ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma
Gespeichert in:
| Veröffentlicht in: | Annals of surgical oncology 2024-09, Vol.31 (9), p.6331-6332 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 6332 |
|---|---|
| container_issue | 9 |
| container_start_page | 6331 |
| container_title | Annals of surgical oncology |
| container_volume | 31 |
| creator | Kouzu, Keita Tsujimoto, Hironori |
| description | |
| doi_str_mv | 10.1245/s10434-024-15732-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3075374828</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3075374828</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-f488ac243563593fed622d8533e1cbed455bb1a51c008456baff5e46e14211253</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhSMEoj_wAizQldh0E_BvJmE3yhSoNNCKAbaRk9xMPErs1HZK5yV5JjxMAYkFK1_5fPfcI50keUHJa8qEfOMpEVykhImUygVnafEoOaUyfoksp4_jTLI8LVgmT5Iz73eE0AUn8mlywvNCClKw0-THcnMNyzn01sFn7AZsgrbGv4UV3uFgpxFNAGVa-KYG3aqDCJswt3uwHYQe4cbZrbE-6Aauxkk14SCsECdYo3JGm226woBu1AZb-Li_t7qNDs6OCpZdFOATWtXu5jsVL5U9jjbaOjXtQRu4iRdjAg_fdejh0tupV1tUA2xuZzXa2UOJwwClco020fJZ8qRTg8fnD-958vXd5ZfyQ7q-fn9VLtdpw2QW0k7kuWqY4DLjsuAdthljbS45R9rU2Aop65oqSRtCciGzWnWdRJEhFYxSJvl5cnH0nZy9ndGHatS-iVGUwZiq4mQh-ULkLI_oq3_QnZ2diekilReEkYKLSLEj1TjrvcOumpweldtXlFSHtqtj21Vsu_rVdlXEpZcP1nM9Yvtn5Xe9EeBHwEfJbNH9vf0f25-Qzrg5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3089020934</pqid></control><display><type>article</type><title>ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Kouzu, Keita ; Tsujimoto, Hironori</creator><creatorcontrib>Kouzu, Keita ; Tsujimoto, Hironori</creatorcontrib><identifier>ISSN: 1068-9265</identifier><identifier>ISSN: 1534-4681</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-024-15732-9</identifier><identifier>PMID: 38954092</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>ASO Author Reflections ; Chemotherapy ; Chemotherapy, Adjuvant ; Deep Learning ; Esophageal cancer ; Esophageal carcinoma ; Esophageal Neoplasms - drug therapy ; Esophageal Neoplasms - pathology ; Esophageal Squamous Cell Carcinoma - drug therapy ; Esophageal Squamous Cell Carcinoma - pathology ; Humans ; Medicine ; Medicine & Public Health ; Neoadjuvant Therapy ; Oncology ; Prognosis ; Squamous cell carcinoma ; Stroma ; Stromal Cells - pathology ; Surgery ; Surgical Oncology ; Survival Rate</subject><ispartof>Annals of surgical oncology, 2024-09, Vol.31 (9), p.6331-6332</ispartof><rights>Society of Surgical Oncology 2024</rights><rights>Society of Surgical Oncology 2024.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-f488ac243563593fed622d8533e1cbed455bb1a51c008456baff5e46e14211253</cites><orcidid>0000-0002-2808-4723</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-024-15732-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-024-15732-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38954092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kouzu, Keita</creatorcontrib><creatorcontrib>Tsujimoto, Hironori</creatorcontrib><title>ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><subject>ASO Author Reflections</subject><subject>Chemotherapy</subject><subject>Chemotherapy, Adjuvant</subject><subject>Deep Learning</subject><subject>Esophageal cancer</subject><subject>Esophageal carcinoma</subject><subject>Esophageal Neoplasms - drug therapy</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Squamous Cell Carcinoma - drug therapy</subject><subject>Esophageal Squamous Cell Carcinoma - pathology</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoadjuvant Therapy</subject><subject>Oncology</subject><subject>Prognosis</subject><subject>Squamous cell carcinoma</subject><subject>Stroma</subject><subject>Stromal Cells - pathology</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><issn>1068-9265</issn><issn>1534-4681</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhSMEoj_wAizQldh0E_BvJmE3yhSoNNCKAbaRk9xMPErs1HZK5yV5JjxMAYkFK1_5fPfcI50keUHJa8qEfOMpEVykhImUygVnafEoOaUyfoksp4_jTLI8LVgmT5Iz73eE0AUn8mlywvNCClKw0-THcnMNyzn01sFn7AZsgrbGv4UV3uFgpxFNAGVa-KYG3aqDCJswt3uwHYQe4cbZrbE-6Aauxkk14SCsECdYo3JGm226woBu1AZb-Li_t7qNDs6OCpZdFOATWtXu5jsVL5U9jjbaOjXtQRu4iRdjAg_fdejh0tupV1tUA2xuZzXa2UOJwwClco020fJZ8qRTg8fnD-958vXd5ZfyQ7q-fn9VLtdpw2QW0k7kuWqY4DLjsuAdthljbS45R9rU2Aop65oqSRtCciGzWnWdRJEhFYxSJvl5cnH0nZy9ndGHatS-iVGUwZiq4mQh-ULkLI_oq3_QnZ2diekilReEkYKLSLEj1TjrvcOumpweldtXlFSHtqtj21Vsu_rVdlXEpZcP1nM9Yvtn5Xe9EeBHwEfJbNH9vf0f25-Qzrg5</recordid><startdate>20240901</startdate><enddate>20240901</enddate><creator>Kouzu, Keita</creator><creator>Tsujimoto, Hironori</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2808-4723</orcidid></search><sort><creationdate>20240901</creationdate><title>ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma</title><author>Kouzu, Keita ; Tsujimoto, Hironori</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-f488ac243563593fed622d8533e1cbed455bb1a51c008456baff5e46e14211253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ASO Author Reflections</topic><topic>Chemotherapy</topic><topic>Chemotherapy, Adjuvant</topic><topic>Deep Learning</topic><topic>Esophageal cancer</topic><topic>Esophageal carcinoma</topic><topic>Esophageal Neoplasms - drug therapy</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Squamous Cell Carcinoma - drug therapy</topic><topic>Esophageal Squamous Cell Carcinoma - pathology</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoadjuvant Therapy</topic><topic>Oncology</topic><topic>Prognosis</topic><topic>Squamous cell carcinoma</topic><topic>Stroma</topic><topic>Stromal Cells - pathology</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kouzu, Keita</creatorcontrib><creatorcontrib>Tsujimoto, Hironori</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kouzu, Keita</au><au>Tsujimoto, Hironori</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2024-09-01</date><risdate>2024</risdate><volume>31</volume><issue>9</issue><spage>6331</spage><epage>6332</epage><pages>6331-6332</pages><issn>1068-9265</issn><issn>1534-4681</issn><eissn>1534-4681</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>38954092</pmid><doi>10.1245/s10434-024-15732-9</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-2808-4723</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1068-9265 |
| ispartof | Annals of surgical oncology, 2024-09, Vol.31 (9), p.6331-6332 |
| issn | 1068-9265 1534-4681 1534-4681 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3075374828 |
| source | MEDLINE; SpringerLink Journals |
| subjects | ASO Author Reflections Chemotherapy Chemotherapy, Adjuvant Deep Learning Esophageal cancer Esophageal carcinoma Esophageal Neoplasms - drug therapy Esophageal Neoplasms - pathology Esophageal Squamous Cell Carcinoma - drug therapy Esophageal Squamous Cell Carcinoma - pathology Humans Medicine Medicine & Public Health Neoadjuvant Therapy Oncology Prognosis Squamous cell carcinoma Stroma Stromal Cells - pathology Surgery Surgical Oncology Survival Rate |
| title | ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A21%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ASO%20Author%20Reflections:%20Development%20and%20Validation%20Study%20of%20the%20Prognostic%20Impact%20of%20Deep%20Learning-Determined%20Myxoid%20Stroma%20After%20Neoadjuvant%20Chemotherapy%20in%20Patients%20with%20Esophageal%20Squamous%20Cell%20Carcinoma&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Kouzu,%20Keita&rft.date=2024-09-01&rft.volume=31&rft.issue=9&rft.spage=6331&rft.epage=6332&rft.pages=6331-6332&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-024-15732-9&rft_dat=%3Cproquest_cross%3E3075374828%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3089020934&rft_id=info:pmid/38954092&rfr_iscdi=true |